https://edgen.pre.edgen.tech/news/post/regenerons-pasatru-wins-fda-approval-cutting-fop-bone-lesions-902026-08-19T18:25:09.418Zdaily1Edgen Stocken2026-08-19T18:25:09.418+00:00Regeneron's Pasatru wins FDA approval, cutting FOP bone lesions 90%https://static.edwealth.ai/news/images/regenerons-pasatru-wins-fda-approval-cutting-fop-bone-lesions-90-20260819.pngRegeneron's Pasatru wins FDA approval, cutting FOP bone lesions 90% https://edgen.pre.edgen.tech/news/post/diesel-hits-7-a-gallon-in-california-as-wars-strain-supply2026-08-19T18:24:01.840Zdaily1Edgen Stocken2026-08-19T18:24:01.840+00:00Diesel hits $7 a gallon in California as wars strain supplyhttps://static.edwealth.ai/news/images/diesel-hits-7-a-gallon-in-california-as-wars-strain-supply-20260819.pngDiesel hits $7 a gallon in California as wars strain supply https://edgen.pre.edgen.tech/news/post/nvidia-weighs-20-billion-mercor-investment-as-open-source-ai-push-grows2026-08-19T18:10:11.913Zdaily1Edgen Stocken2026-08-19T18:10:11.913+00:00Nvidia weighs $20 billion Mercor investment as open-source AI push growshttps://static.edwealth.ai/news/images/nvidia-weighs-20-billion-mercor-investment-as-open-source-ai-push-grows-20260819.pngNvidia weighs $20 billion Mercor investment as open-source AI push grows https://edgen.pre.edgen.tech/news/post/sp-lifts-micron-to-bbb-on-ai-memory-demand-to-20282026-08-19T18:06:38.958Zdaily1Edgen Stocken2026-08-19T18:06:38.958+00:00S&P lifts Micron to BBB+ on AI memory demand to 2028https://static.edwealth.ai/news/images/sp-lifts-micron-to-bbb-on-ai-memory-demand-to-2028-20260819.pngS&P lifts Micron to BBB+ on AI memory demand to 2028 https://edgen.pre.edgen.tech/news/post/fed-minutes-show-hawkish-bias-as-three-officials-back-25bp-hike2026-08-19T18:06:37.446Zdaily1Edgen Stocken2026-08-19T18:06:37.446+00:00Fed Minutes Show Hawkish Bias as Three Officials Back 25bp Hikehttps://static.edwealth.ai/news/images/fed-minutes-show-hawkish-bias-as-three-officials-back-25bp-hike-20260819.pngFed Minutes Show Hawkish Bias as Three Officials Back 25bp Hike https://edgen.pre.edgen.tech/news/post/bitcoin-tops-68000-as-crypto-stocks-strategy-coinbase-bitmine-surge2026-08-19T17:56:39.621Zdaily1Edgen Stocken2026-08-19T17:56:39.621+00:00Bitcoin tops $68,000 as crypto stocks Strategy, Coinbase, Bitmine surgehttps://static.edwealth.ai/news/images/bitcoin-tops-68000-as-crypto-stocks-strategy-coinbase-bitmine-surge-20260819.pngBitcoin tops $68,000 as crypto stocks Strategy, Coinbase, Bitmine surge https://edgen.pre.edgen.tech/news/post/lululemon-loses-third-executive-ahead-of-ceo-oneills-sept-8-start2026-08-19T17:53:15.498Zdaily1Edgen Stocken2026-08-19T17:53:15.498+00:00Lululemon loses third executive ahead of CEO O'Neill's Sept 8 starthttps://static.edwealth.ai/news/images/lululemon-loses-third-executive-ahead-of-ceo-oneills-sept-8-start-20260819.pngLululemon loses third executive ahead of CEO O'Neill's Sept 8 start https://edgen.pre.edgen.tech/news/post/us-halves-canadian-steel-aluminum-tariffs-to-seal-trade-deal2026-08-19T17:51:43.447Zdaily1Edgen Stocken2026-08-19T17:51:43.447+00:00US halves Canadian steel, aluminum tariffs to seal trade dealhttps://static.edwealth.ai/news/images/us-halves-canadian-steel-aluminum-tariffs-to-seal-trade-deal-20260819.pngUS halves Canadian steel, aluminum tariffs to seal trade deal https://edgen.pre.edgen.tech/news/post/openais-zero-retention-data-policy-targets-enterprise-ai-market-in-september2026-08-19T17:37:05.484Zdaily1Edgen Stocken2026-08-19T17:37:05.484+00:00OpenAI's zero-retention data policy targets enterprise AI market in Septemberhttps://static.edwealth.ai/news/images/openais-zero-retention-data-policy-targets-enterprise-ai-market-in-september-20260819.pngOpenAI's zero-retention data policy targets enterprise AI market in September https://edgen.pre.edgen.tech/news/post/gold-climbs-toward-4500-as-treasury-buyback-sinks-yields2026-08-19T17:34:21.048Zdaily1Edgen Stocken2026-08-19T17:34:21.048+00:00Gold climbs toward $4,500 as Treasury buyback sinks yieldshttps://static.edwealth.ai/news/images/gold-climbs-toward-4500-as-treasury-buyback-sinks-yields-20260819.pngGold climbs toward $4,500 as Treasury buyback sinks yields https://edgen.pre.edgen.tech/news/post/sionna-therapeutics-plunges-92-as-sion-719-trial-fails-key-endpoint2026-08-19T17:32:13.286Zdaily1Edgen Stocken2026-08-19T17:32:13.286+00:00Sionna Therapeutics plunges 92% as SION-719 trial fails key endpointhttps://static.edwealth.ai/news/images/sionna-therapeutics-plunges-92-as-sion-719-trial-fails-key-endpoint-20260819.pngSionna Therapeutics plunges 92% as SION-719 trial fails key endpoint https://edgen.pre.edgen.tech/news/post/insulet-faces-aug-31-lead-plaintiff-deadline-after-90-stock-slide2026-08-19T17:31:07.271Zdaily1Edgen Stocken2026-08-19T17:31:07.271+00:00Insulet faces Aug. 31 lead plaintiff deadline after $90 stock slidehttps://static.edwealth.ai/news/images/insulet-faces-aug-31-lead-plaintiff-deadline-after-90-stock-slide-20260819.pngInsulet faces Aug. 31 lead plaintiff deadline after $90 stock slide https://edgen.pre.edgen.tech/news/post/tenax-therapeutics-shares-crash-85-after-tnx-103-trial-misses-endpoints2026-08-19T17:27:38.270Zdaily1Edgen Stocken2026-08-19T17:27:38.270+00:00Tenax Therapeutics shares crash 85% after TNX-103 trial misses endpointshttps://static.edwealth.ai/news/images/tenax-therapeutics-shares-crash-85-after-tnx-103-trial-misses-endpoints-20260819.pngTenax Therapeutics shares crash 85% after TNX-103 trial misses endpoints https://edgen.pre.edgen.tech/news/post/onterris-shares-drop-18-after-q2-miss-triggers-securities-probe2026-08-19T17:27:31.250Zdaily1Edgen Stocken2026-08-19T17:27:31.250+00:00Onterris shares drop 18% after Q2 miss triggers securities probehttps://static.edwealth.ai/news/images/onterris-shares-drop-18-after-q2-miss-triggers-securities-probe-20260819.pngOnterris shares drop 18% after Q2 miss triggers securities probe https://edgen.pre.edgen.tech/news/post/chip-equipment-stocks-fall-5-as-ai-capex-durability-questioned2026-08-19T17:24:05.951Zdaily1Edgen Stocken2026-08-19T17:24:05.951+00:00Chip equipment stocks fall 5% as AI capex durability questionedhttps://static.edwealth.ai/news/images/chip-equipment-stocks-fall-5-as-ai-capex-durability-questioned-20260819.pngChip equipment stocks fall 5% as AI capex durability questioned https://edgen.pre.edgen.tech/news/post/venezuela-opens-916-oil-blocks-to-reverse-output-slide2026-08-19T17:07:07.877Zdaily1Edgen Stocken2026-08-19T17:07:07.877+00:00Venezuela opens 916 oil blocks to reverse output slidehttps://static.edwealth.ai/news/images/venezuela-opens-916-oil-blocks-to-reverse-output-slide-20260819.pngVenezuela opens 916 oil blocks to reverse output slide https://edgen.pre.edgen.tech/news/post/toll-brothers-beats-q3-estimates-as-luxury-demand-holds-steady2026-08-19T16:53:50.883Zdaily1Edgen Stocken2026-08-19T16:53:50.883+00:00Toll Brothers beats Q3 estimates as luxury demand holds steadyhttps://static.edwealth.ai/news/images/toll-brothers-beats-q3-estimates-as-luxury-demand-holds-steady-20260819.pngToll Brothers beats Q3 estimates as luxury demand holds steady https://edgen.pre.edgen.tech/news/post/axt-inp-revenue-hits-record-307m-as-ai-optical-demand-tightens2026-08-19T16:30:28.535Zdaily1Edgen Stocken2026-08-19T16:30:28.535+00:00AXT InP revenue hits record $30.7M as AI optical demand tightenshttps://static.edwealth.ai/news/images/axt-inp-revenue-hits-record-307m-as-ai-optical-demand-tightens-20260819.pngAXT InP revenue hits record $30.7M as AI optical demand tightens https://edgen.pre.edgen.tech/news/post/datavault-ai-buys-cybercatch-for-945-million-in-security-push2026-08-19T16:01:54.127Zdaily1Edgen Stocken2026-08-19T16:01:54.127+00:00Datavault AI Buys CyberCatch for $94.5 Million in Security Pushhttps://static.edwealth.ai/news/images/datavault-ai-buys-cybercatch-for-945-million-in-security-push-20260819.pngDatavault AI Buys CyberCatch for $94.5 Million in Security Push https://edgen.pre.edgen.tech/news/post/biomarin-inks-490m-deal-for-alestas-oral-hpp-therapy2026-08-19T16:00:20.505Zdaily1Edgen Stocken2026-08-19T16:00:20.505+00:00BioMarin inks $490M deal for Alesta's oral HPP therapyhttps://static.edwealth.ai/news/images/biomarin-inks-490m-deal-for-alestas-oral-hpp-therapy-20260819.pngBioMarin inks $490M deal for Alesta's oral HPP therapy